Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan

An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1–10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.

Detalles Bibliográficos
Autores principales: Cheng, Chien-Yu, Lee, Yu-Lin, Chen, Cheng-Pin, Lin, Yi-Chun, Liu, Chun-Eng, Liao, Chia-Hung, Cheng, Shu-Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194913/
https://www.ncbi.nlm.nih.gov/pubmed/32331982
http://dx.doi.org/10.1016/j.jmii.2020.03.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194913/
https://www.ncbi.nlm.nih.gov/pubmed/32331982
http://dx.doi.org/10.1016/j.jmii.2020.03.032

Ejemplares similares